The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.

The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax's COVID-19 vaccine, but only for certain ...

RFK Jr. pledged not to upend US vaccine system, but big changes are underway. It's unclear which shots will be available.

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

US regulators grant full approval to Novavax shot but sharply limit eligibility. New studies on heart risks required, raising ...

A new report says Health and Human Services Secretary Robert F. Kennedy Jr. will roll back current CDC guidance on COVID ...

An FDA advisory committee is scheduled to meet to discuss the formula for the next COVID-19 vaccines after being sidelined ...